Short communication
Involvement of endogenous nitric oxide in the regulation of rat intestinal motility in vivo

https://doi.org/10.1016/0014-2999(92)90567-NGet rights and content

Abstract

The effect of the nitric oxide (NO) synthase inhibitor, NG-nitro-L-arginine methyl ester (L-NAME) on the motility of the small intestine in an acute model in the anaesthetised rat was determined by changes in jejunal intraluminal pressure. L-NAME (0.5–10 mg kg−1 i.v.) caused a dose-dependent increase in intraluminal pressure and initiated phasic intestinal contractions. These responses were inhibited by concurrent administration of L-arginine (200 mg kg−1 i.v.) but not by D-arginine (200 mg kg−1). The increase in jejunal motility induced by L-NAME was attenuated by atropine (4 mg kg−1), although even high doses of atropine (16 mg kg−1) did not abolish these responses. This indicates that although there are interactions between NO and muscarinic cholinergic mechanisms, other processes are also involved in these contractile events following administration of L-NAME. These observations in the rat suggest that endogenous NO plays a role in the modulation of intestinal motility in vivo.

References (15)

There are more references available in the full text version of this article.

Cited by (110)

  • Increase of n-NOS and i-NOS in Rat Colon After Sacral Neuromodulation

    2017, Neuromodulation
    Citation Excerpt :

    It has been demonstrated how the synthesis of NO can play a key role in intestinal motility. Calignano et al. demonstrated how the administration of the NO synthase inhibitor, L-NAME, correlates with an increased intestinal motility, defined as increased intraluminal jejunal pressure and small bowel peristaltic contractions, in an in vivo rat model (24). Different studies demonstrated the implication of NO in small bowel motility both in rats and humans (25,26).

View all citing articles on Scopus
View full text